SAMDaily.us | SNOTE | 65 | Notice of Intent to Sole Source: ERVEBO

SAMDAILY.US - ISSUE OF JULY 11, 2024 SAM #8262
SPECIAL NOTICE

65 -- Notice of Intent to Sole Source: ERVEBO

Notice Date: 7/9/2024 8:40:17 AM
Notice Type: Special Notice
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Response Due: 7/24/2024 1:00:00 PM
Archive Date: 08/08/2024
Point of Contact: Jonathan Gonzalez, Contracting Officer, Yifan Yang
E-Mail Address: Jonathan.Gonzalez@hhs.gov, yifan.yang@hhs.gov
(Jonathan.Gonzalez@hhs.gov, yifan.yang@hhs.gov)
Description: The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Biomedical Advanced Research & Development Authority (BARDA) intends to use other than full and open competition to award a sole source contract to Merck Sharp & Dohme LLC to procure up to 1,000,000 licensed doses of ERVEBO, a vaccine for protection against EBOV, VMI storage of doses, extending expiry of doses, and develop a new manufacturing process using bioreactors.��
Web Link: SAM.gov Permalink
(https://sam.gov/opp/7160785f397544dc856a314d3c8171a2/view)
Place of Performance: Address: Washington, DC, USA; Country: USA
Record: SN07120899-F 20240711/240709230106 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |